Twist Bioscience Corporation (BIT:1TWST)

Twist Bioscience Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Cap	1,620	2,289	1,004	1,714	4,557	2,947
Market Cap Growth	-32.46%	128.12%	-41.46%	-62.38%	54.60%	336.30%
Enterprise Value	1,484	2,112	782.16	1,350	4,191	2,720
PE Ratio	-	-12.55	-5.63	-8.72	-33.96	-21.28
PS Ratio	5.25	8.50	4.76	9.78	40.01	38.01
PB Ratio	3.98	5.63	1.87	2.52	9.12	10.19
P/TBV Ratio	3.30	5.55	1.85	2.41	8.89	8.85
P/FCF Ratio	-	-38.46	-6.85	-8.80	-38.01	-22.51
P/OCF Ratio	-	-41.50	-8.18	-16.01	-47.17	-24.08
EV/Sales Ratio	4.76	7.84	3.71	7.70	36.80	35.09
EV/EBITDA Ratio	-	-12.96	-4.84	-7.18	-34.06	-23.70
EV/EBIT Ratio	-	-11.11	-4.19	-6.68	-31.89	-22.57
EV/FCF Ratio	-25.36	-35.48	-5.34	-6.93	-34.96	-20.78
Debt / Equity Ratio	0.13	0.15	0.13	0.10	0.09	0.08
Debt / EBITDA Ratio	-0.67	-0.45	-0.50	-0.43	-0.44	-0.27
Debt / FCF Ratio	-1.14	-1.23	-0.55	-0.42	-0.45	-0.24
Asset Turnover	0.58	0.45	0.28	0.24	0.24	0.31
Inventory Turnover	7.44	6.40	4.35	3.36	3.66	6.26
Quick Ratio	3.45	4.38	5.19	6.01	8.03	8.78
Current Ratio	3.90	4.88	5.79	6.58	8.67	9.29
Return on Equity (ROE)	-27.02%	-36.91%	-28.45%	-34.52%	-33.41%	-56.85%
Return on Assets (ROA)	-22.67%	-31.67%	-24.85%	-29.53%	-28.10%	-47.69%
Return on Capital (ROIC)	-45.74%	-65.01%	-54.77%	-84.73%	-116.40%	-240.41%
Return on Capital Employed (ROCE)	-25.99%	-35.44%	-27.60%	-31.10%	-30.49%	-53.93%
Earnings Yield	-4.48%	-7.97%	-17.77%	-11.46%	-2.94%	-4.70%
FCF Yield	-3.61%	-2.60%	-14.60%	-11.36%	-2.63%	-4.44%
Buyback Yield / Dilution	-0.34%	-0.26%	-0.08%	-13.66%	-6.28%	-8.97%
Total Shareholder Return	-	-0.26%	-0.08%	-13.66%	-6.28%	-8.97%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.